Insider · CIK 0001789317

Drappa Jorn

Reports to the SEC for 4 companies · SOUTH SAN FRANCISCO, CA

sec.gov

Transactions

Companies

Filings

CIK

0001789317

Forms 4 and 5

Insider transactions

38 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-08-03	ALMSALUMIS INC.S Sale	Chief Medical Officer	SSale	−2,447 sh	$26.37	−$64.5K	56,892
2026-05-22	ALMSALUMIS INC.M Exercise/Conversion	Chief Medical Officer	MExercise/Conversion	+11.3K sh	$8.84	+$100K	43,804
2026-05-22	ALMSALUMIS INC.M Exercise/Conversion	Chief Medical Officer	MExercise/Conversion	+15.5K sh	$5.06	+$78.6K	59,339
2026-05-22	ALMSALUMIS INC. · Stock Option (Right to Buy)M Exercise/Conversion	Chief Medical Officer	MExercise/Conversion	−11.3K sh	—	—	159,805
2026-05-22	ALMSALUMIS INC. · Stock Option (Right to Buy)M Exercise/Conversion	Chief Medical Officer	MExercise/Conversion	−15.5K sh	—	—	164,465
2026-01-26	ALMSALUMIS INC. · Stock Option (Right to Buy)A Award	Chief Medical Officer	AAward	+221K sh	—	—	221,450
2025-07-29	ALMSALUMIS INC.A Award	Chief Medical Officer	AAward	+25.5K sh	—	—	28,450
2025-07-29	ALMSALUMIS INC. · Stock Option (Right to Buy)A Award	Chief Medical Officer	AAward	+102K sh	—	—	101,850
2025-02-18	ALMSALUMIS INC. · Stock Option (Right to Buy)A Award	Chief Medical Officer	AAward	+180K sh	—	—	180,000
2024-07-01	ALMSALUMIS INC. · Stock Option (Right to Buy)D Disposition to Issuer	Chief Medical Officer	DDisposition to Issuer	−5,347 sh	—	—	0
2024-07-01	ALMSALUMIS INC. · Stock Option (Right to Buy)A Award	Chief Medical Officer	AAward	+5,347 sh	—	—	5,347
2024-07-01	ALMSALUMIS INC. · Stock Option (Right to Buy)D Disposition to Issuer	Chief Medical Officer	DDisposition to Issuer	−85.6K sh	—	—	0
2024-07-01	ALMSALUMIS INC. · Stock Option (Right to Buy)A Award	Chief Medical Officer	AAward	+85.6K sh	—	—	85,561
2024-07-01	ALMSALUMIS INC. · Stock Option (Right to Buy)D Disposition to Issuer	Chief Medical Officer	DDisposition to Issuer	−171K sh	—	—	0
2024-07-01	ALMSALUMIS INC. · Stock Option (Right to Buy)A Award	Chief Medical Officer	AAward	+171K sh	—	—	171,122
2024-07-01	ALMSALUMIS INC. · Stock Option (Right to Buy)D Disposition to Issuer	Chief Medical Officer	DDisposition to Issuer	−12.8K sh	—	—	0
2024-07-01	ALMSALUMIS INC. · Stock Option (Right to Buy)A Award	Chief Medical Officer	AAward	+12.8K sh	—	—	12,834
2024-07-01	ALMSALUMIS INC. · Stock Option (Right to Buy)D Disposition to Issuer	Chief Medical Officer	DDisposition to Issuer	−18.7K sh	—	—	0
2024-07-01	ALMSALUMIS INC. · Stock Option (Right to Buy)A Award	Chief Medical Officer	AAward	+18.7K sh	—	—	18,652
2024-07-01	ALMSALUMIS INC. · Stock Option (Right to Buy)D Disposition to Issuer	Chief Medical Officer	DDisposition to Issuer	−54.5K sh	—	—	0
2024-07-01	ALMSALUMIS INC. · Stock Option (Right to Buy)A Award	Chief Medical Officer	AAward	+54.5K sh	—	—	54,545
2024-07-01	ALMSALUMIS INC. · Stock Option (Right to Buy)D Disposition to Issuer	Chief Medical Officer	DDisposition to Issuer	−70.8K sh	—	—	0
2024-07-01	ALMSALUMIS INC. · Common Stock (Right to Buy)A Award	Chief Medical Officer	AAward	+70.8K sh	—	—	70,802
2024-07-01	ALMSALUMIS INC. · Stock Option (Right to Buy)D Disposition to Issuer	Chief Medical Officer	DDisposition to Issuer	−64.2K sh	—	—	0
2024-07-01	ALMSALUMIS INC. · Stock Option (Right to Buy)A Award	Chief Medical Officer	AAward	+64.2K sh	—	—	64,171
2024-06-27	ALMSALUMIS INC. · Stock Option (Right to Buy)A Award	Chief Medical Officer	AAward	+5,347 sh	—	—	5,347
2024-05-20	ALPINE IMMUNE SCIENCES, INC.Stock Option (Right to buy)D Disposition to Issuer	Director	DDisposition to Issuer	−20K sh	—	—	0
2024-05-20	ALPINE IMMUNE SCIENCES, INC.Stock Option (Right to buy)D Disposition to Issuer	Director	DDisposition to Issuer	−10K sh	—	—	0
2024-05-20	ALPINE IMMUNE SCIENCES, INC.Stock Option (Right to buy)D Disposition to Issuer	Director	DDisposition to Issuer	−17.5K sh	—	—	0
2024-01-02	ALPINE IMMUNE SCIENCES, INC.Stock Option (Right to buy)A Award	Director	AAward	+17.5K sh	—	—	17,500
2023-01-03	ALPINE IMMUNE SCIENCES, INC.Stock Option (Right to buy)A Award	Director	AAward	+10K sh	—	—	10,000
2022-07-18	ALPINE IMMUNE SCIENCES, INC.Stock Option (Right to buy)A Award	Director	AAward	+20K sh	—	—	20,000
2022-02-04	VTYXVentyx Biosciences, Inc. · Stock Option (right to buy)A Award	Chief Medical Officer	AAward	+145K sh	—	—	145,000
2021-03-15	Viela Bio, Inc.Stock Option (right to buy)D Disposition to Issuer	Chief Medical Officer	DDisposition to Issuer	−71.8K sh	—	—	0
2021-03-15	Viela Bio, Inc.Stock Option (right to buy)D Disposition to Issuer	Chief Medical Officer	DDisposition to Issuer	−64K sh	—	—	0
2021-03-15	Viela Bio, Inc.Stock Option (right to buy)D Disposition to Issuer	Chief Medical Officer	DDisposition to Issuer	−165K sh	—	—	0
2021-03-13	Viela Bio, Inc.D Disposition to Issuer	Chief Medical Officer	DDisposition to Issuer	−203K sh	$53.00	−$10.7M	0
2020-03-02	Viela Bio, Inc.Stock Option (Right to Buy)A Award	Chief Medical Officer	AAward	+71.8K sh	—	—	71,842

Recent filings

Accepted (ET)
Aug 54
Drappa Jorn0001789317-26-000007
SEC(opens sec.gov)
May 274
Drappa Jorn0001789317-26-000005
SEC(opens sec.gov)
Jan 284
Drappa Jorn0001789317-26-000003
SEC(opens sec.gov)
Jul 314
Drappa Jorn0001415889-25-020803
SEC(opens sec.gov)
Feb 204
Drappa Jorn0001415889-25-004938
SEC(opens sec.gov)
Jul 14
Drappa Jorn0001415889-24-018592
SEC(opens sec.gov)

Companies

Address

C/O ALUMIS INC. 280 EAST GRAND AVENUE

SOUTH SAN FRANCISCO, CA, 94080